Sleep disorders

On this page

🌙 Sleep Disorders: The Nocturnal Medicine Frontier

Sleep disorders affect nearly one-third of adults, yet they remain underdiagnosed gateways to cardiovascular disease, metabolic dysfunction, and cognitive decline. You'll master sleep architecture, navigate the diagnostic framework from insomnia to narcolepsy, and build treatment algorithms that restore restorative sleep. By integrating pathophysiology with clinical tools-from polysomnography interpretation to CPAP titration-you'll transform nocturnal complaints into precise diagnoses and evidence-based interventions that protect both brain and body.

🌙 Sleep Disorders: The Nocturnal Medicine Frontier

🏗️ Sleep Architecture Mastery: The Nocturnal Blueprint

📌 Remember: NREM 1-2-3-REM cycles repeat 4-6 times nightly - N1 (5%), N2 (45%), N3 (25%), REM (25%)

Sleep Stage Characteristics and Clinical Significance

StageDurationEEG PatternPhysiological ChangesClinical RelevancePathology Markers
NREM 12-5% total4-7 Hz theta waves↓50% muscle toneLight sleep, easy arousal>10% suggests fragmentation
NREM 245-55% totalSleep spindles, K-complexes↓body temperature 1-2°CMemory consolidation<40% indicates disorder
NREM 315-25% total<2 Hz delta waves↓80% muscle toneGrowth hormone release<15% impairs recovery
REM20-25% totalBeta-like activityComplete muscle atoniaEmotional processing<15% suggests depression
  • 75-84%: Mild impairment requiring evaluation
  • <75%: Significant sleep disorder likely present
    • Sleep onset latency: Normal <20 minutes
    • REM latency: Normal 60-120 minutes

Clinical Pearl: REM latency <45 minutes suggests major depression with 85% sensitivity, while sleep efficiency <75% predicts cardiovascular events with relative risk 1.8

Detailed hypnogram showing normal sleep architecture with NREM and REM cycles

  • Circadian Rhythm Integration
    • Core body temperature nadir: 4-6 AM (lowest 36.1°C)
    • Melatonin peak: 2-4 AM (levels 10-fold higher than daytime)
      • Cortisol awakening response: 50-75% increase within 30 minutes
      • Growth hormone surge: 70% released during NREM 3

💡 Master This: Sleep architecture disruption creates bidirectional relationships with medical conditions - sleep apnea increases cardiovascular risk 2.9-fold, while heart failure fragments sleep in >80% of patients

Understanding sleep architecture patterns enables recognition of specific sleep disorders through characteristic polysomnographic signatures. This foundation connects directly to diagnostic approaches that differentiate between primary sleep disorders and secondary sleep disruption from medical conditions.

🏗️ Sleep Architecture Mastery: The Nocturnal Blueprint

⚡ Sleep Disorder Classification: The Diagnostic Framework

📌 Remember: ICSD-3 Categories - Insomnia, Breathing, Hypersomnia, Circadian, Parasomnias, Movement (I Buy Heavy Coffee, Please Move)

Major Sleep Disorder Categories with Prevalence Data

  • Insomnia Disorders (10-15% population prevalence)

    • Chronic insomnia: ≥3 nights/week for ≥3 months
    • Short-term insomnia: <3 months duration
      • Comorbid insomnia: Associated with medical/psychiatric conditions
      • Primary insomnia: No identifiable underlying cause
  • Sleep-Related Breathing Disorders (9-24% adult prevalence)

    • Obstructive Sleep Apnea: AHI ≥5 with symptoms or ≥15 without
    • Central Sleep Apnea: ≥50% central events of total respiratory events
      • Sleep-related hypoventilation: CO2 >55 mmHg or ↑10 mmHg from wake

Clinical Pearl: OSA prevalence increases exponentially with age - 3-7% in middle-aged adults, >20% in adults >65 years, with male predominance 2-3:1 until menopause

Disorder CategoryKey Diagnostic ThresholdPrimary SymptomsPolysomnographic FindingsTreatment Response Rate
Chronic Insomnia≥3 nights/week, ≥3 monthsDifficulty initiating/maintaining sleepSleep efficiency <85%CBT-I: 70-80%
OSAAHI ≥5 + symptomsSnoring, witnessed apneasRespiratory events ≥5/hourCPAP: 85-95%
Narcolepsy Type 1Cataplexy + MSLT ≤8 minExcessive sleepiness, cataplexyREM latency <15 minStimulants: 60-80%
RLSUrge to move + circadianUncomfortable leg sensationsPLMS index >15/hourDopamine agonists: 75-85%
NREM ParasomniaComplex behaviors from N3Sleepwalking, night terrorsArousals from slow-waveSafety measures: 90%
  • Narcolepsy Type 1: Cataplexy + MSLT ≤8 minutes + ≥2 SOREMPs
  • Narcolepsy Type 2: No cataplexy + MSLT ≤8 minutes + ≥2 SOREMPs
    • Idiopathic hypersomnia: MSLT ≤8 minutes + <2 SOREMPs
    • Kleine-Levin syndrome: Recurrent episodes lasting days to weeks

💡 Master This: Polysomnographic patterns provide diagnostic fingerprints - OSA shows repetitive respiratory events, narcolepsy demonstrates sleep-onset REM periods, while RLS reveals periodic limb movements >15/hour

This classification framework enables systematic diagnostic approaches, connecting specific symptom patterns to targeted testing strategies and evidence-based treatment protocols for optimal patient outcomes.

⚡ Sleep Disorder Classification: The Diagnostic Framework

🔍 Diagnostic Mastery: The Sleep Detective Toolkit

📌 Remember: Sleep History BEARS - Bedtime routine, Excessive sleepiness, Awakenings, Regularity, Snoring (Bears Eat All Raw Salmon)

Comprehensive Sleep Assessment Framework

  • Clinical History Components (Diagnostic yield 60-70%)

    • Sleep-wake schedule: Bedtime, wake time, sleep latency >30 minutes
    • Sleep quality indicators: Awakenings >2/night, sleep efficiency <85%
      • Daytime symptoms: Epworth Sleepiness Scale >10
      • Bed partner observations: Witnessed apneas, loud snoring
  • Physical Examination Targets

    • BMI assessment: OSA risk increases 10% per 1 kg/m² increase
    • Neck circumference: >17 inches (men), >16 inches (women) predicts OSA
      • Mallampati score: Class III-IV increases OSA likelihood 3-fold
      • Nasal patency: Deviated septum present in 40% of OSA patients

Clinical Pearl: STOP-BANG score ≥3 predicts moderate-severe OSA with 84% sensitivity and 56% specificity - Snoring, Tiredness, Observed apneas, Pressure, BMI >35, Age >50, Neck >40cm, Gender (male)

Assessment ToolSensitivitySpecificityClinical ApplicationThreshold ValuesDiagnostic Yield
Epworth Sleepiness Scale93.5%31%Excessive daytime sleepiness>10 abnormalHypersomnolence screening
STOP-BANG84%56%OSA screening≥3 high riskPre-surgical evaluation
Pittsburgh Sleep Quality89.6%86.5%Sleep quality assessment>5 poor sleepInsomnia evaluation
Berlin Questionnaire86%77%OSA risk stratification≥2 categoriesPrimary care screening
Insomnia Severity Index86.1%87.7%Insomnia severity≥15 clinical insomniaTreatment monitoring
%%{init: {'flowchart': {'htmlLabels': true}}}%%
flowchart TD

Start["📋 Sleep Complaint
• Initial patient view• Rule out causes"]

ExSleep["⚖️ Excessive Sleep?
• Daytime fatigue• Evaluate severity"]

ESS["📋 ESS >10?
• Epworth Scale• Assess drowsiness"]

DiffSleep["⚖️ Difficulty Sleeping?
• Sleep initiation• Maintenance issues"]

StopBang["📋 STOP-BANG >=3?
• OSA screening• Risk assessment"]

Hypersom["🩺 Hypersomnia
• Multiple causes• Follow-up needed"]

ISI["📋 ISI >=15?
• Insomnia Index• Severity check"]

Parasom["🩺 Parasomnia/Move
• Abnormal conduct• Move disorders"]

OSA["🔬 Sleep Study/OSA
• Polysomnography• Check apnea index"]

MSLT["🔬 MSLT Narcolepsy
• Latency testing• NREM periods"]

CBTI["💊 CBT-I Trial
• First-line therapy• Cognitive therapy"]

Hygiene["💊 Sleep Hygiene
• Bedtime habits• Routine education"]

Start --> ExSleep ExSleep -->|Yes| ESS ExSleep -->|No| DiffSleep ESS -->|Yes| StopBang ESS -->|No| Hypersom StopBang -->|Yes| OSA StopBang -->|No| MSLT DiffSleep -->|Yes| ISI DiffSleep -->|No| Parasom ISI -->|Yes| CBTI ISI -->|No| Hygiene

style Start fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style ExSleep fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style ESS fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style DiffSleep fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style StopBang fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style ISI fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style Hypersom fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8 style Parasom fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8 style OSA fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C style MSLT fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C style CBTI fill:#F1FCF5, stroke:#BEF4D8, stroke-width:1.5px, rx:12, ry:12, color:#166534 style Hygiene fill:#F1FCF5, stroke:#BEF4D8, stroke-width:1.5px, rx:12, ry:12, color:#166534


* **Objective Testing Indications**
  - **Polysomnography**: **Gold standard** for **OSA**, **parasomnias**, **PLMD**
  - **Home Sleep Apnea Testing**: **Moderate-high OSA probability** without comorbidities
    + **Multiple Sleep Latency Test**: **Narcolepsy** and **idiopathic hypersomnia**
    + **Actigraphy**: **Circadian rhythm disorders** and **insomnia assessment**

> 💡 **Master This**: **Diagnostic efficiency** improves with **pre-test probability assessment** - **high clinical suspicion** (STOP-BANG ≥5) yields **OSA diagnosis** in **>90%** of cases, while **low suspicion** requires **comprehensive evaluation**

![Sleep study equipment setup showing polysomnography monitoring devices](https://ylbwdadhbcjolwylidja.supabase.co/storage/v1/object/public/notes/topic/sleep-disorders/sleep-disorders-sleep-study-polysomnography-eq-1754041688303.webp)

This systematic diagnostic approach enables targeted testing strategies, connecting clinical presentations to specific sleep disorders while optimizing resource utilization and diagnostic accuracy for improved patient outcomes.

🔍 Diagnostic Mastery: The Sleep Detective Toolkit

⚖️ Treatment Algorithm Mastery: The Therapeutic Decision Tree

📌 Remember: Treatment Hierarchy FIRST - First-line evidence-based, Individualized approach, Risk-benefit analysis, Side effect profile, Titration protocol (First I Risk Side Titration)

Evidence-Based Treatment Selection Matrix

  • Obstructive Sleep Apnea Treatment Efficacy
    • CPAP therapy: AHI reduction 85-95%, adherence 60-70% at 1 year
    • Oral appliances: AHI reduction 50-70%, better tolerance 80-90%
      • Surgical options: Success rates 30-60% depending on procedure
      • Weight loss: 10% reduction decreases AHI by 26%
Treatment ModalityEfficacy RateAdherence RateSide Effect ProfileCost EffectivenessPatient Selection
CPAP Therapy85-95% AHI reduction60-70% long-termMask discomfort 40%$2,500-4,000/yearAll OSA severities
Oral Appliances50-70% AHI reduction80-90% toleranceDental changes 15%$1,500-3,000Mild-moderate OSA
CBT-I70-80% insomnia improvement85-90% completionMinimal side effects$1,200-2,000Chronic insomnia
Modafinil60-80% sleepiness reduction75-85% adherenceHeadache 34%$3,000-5,000/yearNarcolepsy, shift work
Dopamine Agonists75-85% RLS improvement70-80% long-termImpulse control 15%$1,000-3,000/yearModerate-severe RLS
  • Insomnia Treatment Hierarchy

    • First-line: Cognitive Behavioral Therapy for Insomnia (CBT-I)
    • Second-line: Sleep medications for <4 weeks duration
      • Sleep restriction therapy: Sleep efficiency >85% in 60-70% patients
      • Stimulus control: Bed = sleep only association strengthening
  • Narcolepsy Management Protocol

    • Modafinil/Armodafinil: 200-250 mg daily, onset 1-2 hours
    • Sodium oxybate: 4.5-9 g nightly, cataplexy reduction 85%
      • Stimulant combinations: Methylphenidate 20-60 mg for refractory cases
      • Antidepressants: Venlafaxine 75-225 mg for cataplexy control

💡 Master This: Treatment success requires combination approaches - OSA patients benefit from CPAP + weight loss + sleep position therapy, while insomnia responds best to CBT-I + sleep hygiene + circadian optimization

This systematic treatment approach enables personalized therapy selection, connecting specific diagnostic findings to evidence-based interventions that optimize sleep quality and long-term health outcomes.

⚖️ Treatment Algorithm Mastery: The Therapeutic Decision Tree

🧠 Pathophysiology Integration: The Sleep-Health Nexus

📌 Remember: Sleep-Health Connections CHIME - Cardiovascular, Hormonal, Immune, Metabolic, Emotional (Chimes Help Identify Medical Effects)

Multi-System Sleep Disorder Impact

  • Cardiovascular Consequences (Risk amplification 2-4 fold)

    • OSA: Sympathetic activation increases blood pressure 5-10 mmHg
    • Sleep fragmentation: Inflammatory markers (CRP, IL-6) ↑200-300%
      • Atrial fibrillation risk: OSA patients 2.18-fold increased incidence
      • Stroke risk: Severe OSA increases risk 3.3-fold independent of hypertension
  • Metabolic Disruption Mechanisms

    • Sleep restriction: Glucose tolerance impaired after 4 days of <6 hours sleep
    • Insulin sensitivity: ↓25% with chronic sleep deprivation
      • Leptin levels: ↓18% with sleep restriction (appetite regulation)
      • Ghrelin levels: ↑28% promoting increased caloric intake

Clinical Pearl: Sleep duration <6 hours increases diabetes risk 1.28-fold and obesity risk 1.55-fold, while OSA independently increases metabolic syndrome prevalence from 18% to 60%

System AffectedSleep Disorder ImpactQuantitative RiskMechanismClinical ManifestationIntervention Benefit
CardiovascularHTN, MI, stroke2-4 fold ↑ riskSympathetic activationBP ↑5-10 mmHgCPAP ↓BP 2-10 mmHg
MetabolicDM, obesity1.3-1.6 fold ↑Insulin resistanceGlucose ↑15-20%Sleep Rx ↓HbA1c 0.5%
ImmuneInfection susceptibility3-fold ↑ URICytokine dysregulationVaccine response ↓50%Sleep restoration normalizes
CognitiveMemory, attentionPerformance ↓25%Glymphatic clearanceReaction time ↑50%Sleep therapy ↑cognition
PsychiatricDepression, anxiety2-3 fold ↑ riskNeurotransmitter imbalanceMood scores ↓30%Sleep Rx ↓depression 40%
%%{init: {'flowchart': {'htmlLabels': true}}}%%
flowchart TD

Root["😴 Sleep Disruption
• Circadian rhythm• Poor sleep quality"]

Symp["⚡ Sympathetic Activity
• Adrenergic surge• Fight or flight"]

HPA["🧠 HPA Axis
• Dysregulation• Stress response"]

Inflam["🔥 Inflammation
• Systemic response• Chronic state"]

HTN["🩸 Hypertension
• ⬆️ Blood pressure• Vascular strain"]

Arr["💓 Arrhythmias
• Heart rate flux• Rhythm instability"]

CVE["⚠️ CV Events
• Heart attack/Stroke• Acute vascular issue"]

Cort["🧪 ⬆️ Cortisol
• Steroid elevation• Glucocorticoids"]

Insul["🍭 Insulin Resist.
• ⬇️ Glucose uptake• Hyperinsulinemia"]

MetS["⚖️ Metabolic Synd.
• Lipid profile shift• Central obesity"]

Cyto["🧬 Cytokine Release
• IL-6 and TNF-alpha• Pro-inflammatory"]

Endo["🧱 Endothelial Dys.
• Vessel wall injury• ⬇️ Nitric oxide"]

Immune["🛡️ Immune Suppress.
• ⬇️ Defense system• Infection risk"]

Root --> Symp Root --> HPA Root --> Inflam

Symp --> HTN Symp --> Arr HTN --> CVE

HPA --> Cort HPA --> Insul Insul --> MetS

Inflam --> Cyto Inflam --> Endo Cyto --> Immune

style Root fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8 style Symp fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style HPA fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style Inflam fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style HTN fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C style Arr fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C style CVE fill:#FDF4F3, stroke:#FCE6E4, stroke-width:1.5px, rx:12, ry:12, color:#B91C1C style Cort fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C style Insul fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C style MetS fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8 style Cyto fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C style Endo fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C style Immune fill:#F6F5F5, stroke:#E7E6E6, stroke-width:1.5px, rx:12, ry:12, color:#525252


* **Neurological Integration Patterns**
  - **Glymphatic system**: **Sleep** increases **clearance 60%** of **amyloid-β** and **tau**
  - **Memory consolidation**: **REM sleep** critical for **procedural learning**
    + **Alzheimer's risk**: **Sleep disorders** increase **dementia risk 1.5-2 fold**
    + **Seizure threshold**: **Sleep deprivation** lowers **threshold 40-60%**

* **Bidirectional Disease Relationships**
  - **Heart failure**: **Sleep apnea** present in **50-75%** of patients
  - **Depression**: **Insomnia** precedes **mood episodes** in **69%** of cases
    + **COPD**: **Sleep quality** correlates with **exacerbation frequency**
    + **Chronic pain**: **Sleep disruption** amplifies **pain perception 25%**

> 💡 **Master This**: **Sleep optimization** provides **multiplicative health benefits** - treating **OSA** reduces **cardiovascular events 68%**, **diabetes progression 43%**, and **depression symptoms 52%** through **shared pathway restoration**

This pathophysiological understanding enables comprehensive treatment approaches that address sleep disorders as systemic conditions, optimizing both sleep quality and overall health outcomes through targeted interventions.

🎯 Clinical Mastery Arsenal: The Sleep Medicine Toolkit

📌 Remember: Mastery Framework SLEEP - Systematic assessment, Logical diagnosis, Evidence-based treatment, Effective monitoring, Patient outcomes (Sleep Like Every Expert Physician)

Essential Clinical Decision Tools

  • Rapid Assessment Protocol (Diagnostic efficiency >85%)

    • Primary complaint triage: Sleepiness vs. insomnia vs. parasomnia
    • Risk stratification: STOP-BANG, Epworth, sleep diary
      • Physical examination: BMI, neck circumference, airway assessment
      • Comorbidity screening: Cardiovascular, psychiatric, neurological
  • Treatment Selection Matrix

    • OSA severity-based: Mild (lifestyle), Moderate (CPAP), Severe (multimodal)
    • Insomnia duration-based: Acute (hygiene), Chronic (CBT-I)
      • Hypersomnia type-based: Narcolepsy (stimulants), Idiopathic (modafinil)
      • Movement disorder-based: RLS (dopamine), PLMD (gabapentin)

Clinical Pearl: Treatment adherence improves 40-60% with patient education, follow-up protocols, and side effect management - CPAP adherence increases from 60% to 85% with comprehensive support programs

Clinical ScenarioFirst-Line ApproachSuccess RateMonitoring ProtocolAdjustment CriteriaLong-term Outcomes
Moderate OSACPAP + education85-90%30/90-day follow-upAHI <5, adherence >4hCV risk ↓30%
Chronic InsomniaCBT-I program70-80%Weekly sessions x6Sleep efficiency >85%Sustained 85% at 2y
Narcolepsy Type 1Modafinil + sodium oxybate60-75%Monthly titrationESS <10, no cataplexyQOL improvement 60%
Severe RLSPramipexole 0.25mg75-85%2-week intervalsIRLS <15Symptom control 70%
Shift Work DisorderMelatonin + light therapy50-70%Sleep diary monitoringSleep efficiency >80%Adaptation 60%
%%{init: {'flowchart': {'htmlLabels': true}}}%%
flowchart TD

A["😴 Sleep Complaint
• Patient history• Initial symptoms"] B["📋 Systemic Assess
• Clinical exam• Comorbid check"] C["⚠️ Risk Stratify
• Severity levels• Safety screening"] D["🔬 Targeted Test
• Polysomnography• Sleep actigraphy"] E["💊 Evidence-Based Tx
• Guideline meds• Sleep therapy"] F["👁️ Monitor Protocol
• Follow-up visits• Track progress"] G{"❓ Goals Met?
• Outcome check• Goal review"} H["✅ Maintenance Care
• Long-term health• Stable symptoms"] I["🔄 Tx Adjustment
• Modify dosage• Try new therapy"]

A --> B B --> C C --> D D --> E E --> F F --> G G -->|Yes| H G -->|No| I I --> F

style A fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8 style B fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style C fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style D fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C style E fill:#F1FCF5, stroke:#BEF4D8, stroke-width:1.5px, rx:12, ry:12, color:#166534 style F fill:#EEFAFF, stroke:#DAF3FF, stroke-width:1.5px, rx:12, ry:12, color:#0369A1 style G fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style H fill:#F6F5F5, stroke:#E7E6E6, stroke-width:1.5px, rx:12, ry:12, color:#525252 style I fill:#F1FCF5, stroke:#BEF4D8, stroke-width:1.5px, rx:12, ry:12, color:#166534


* **Quality Metrics and Outcomes**
  - **Sleep efficiency target**: **>85%** for **restorative sleep**
  - **AHI reduction goal**: **<5 events/hour** for **OSA treatment**
    + **Adherence thresholds**: **CPAP >4 hours/night**, **CBT-I >80% sessions**
    + **Symptom improvement**: **ESS reduction >3 points**, **ISI reduction >7 points**

> 💡 **Master This**: **Sleep medicine success** requires **longitudinal care** with **systematic monitoring** - **treatment failures** often result from **inadequate follow-up** rather than **inappropriate therapy selection**

This clinical mastery framework enables systematic approach to sleep disorders, connecting diagnostic precision with evidence-based treatments to achieve optimal patient outcomes and long-term sleep health restoration.

🎯 Clinical Mastery Arsenal: The Sleep Medicine Toolkit

Practice Questions: Sleep disorders

Test your understanding with these related questions

A 45-year-old obese man presents to his primary care provider for an annual physical. The patient states that he has noticed increased sleepiness during the day at work over the past 6 months in addition to difficulty concentrating and worsening memory. He denies recent weight loss, and is not sure if he snores because he sleeps by himself. His past medical history is significant for hypertension and type II diabetes. Vital signs are T 98.6 F, HR 75 bpm, BP 140/90 mm Hg, RR 18/min. Physical exam reveals a 350 pound man. Jugular venous distension is difficult to evaluate due to excess tissue in the neck. There is no peripheral edema. Lung exam is normal. Routine CBC shows WBC count of 5000 cells/ml, platelet count of 350,000/mcL, hemoglobin of 18 gm/dL, and hematocrit of 54%. What is the most likely cause of his abnormal lab results?

1 of 5

Flashcards: Sleep disorders

1/10

Depression is associated with _____ total REM sleep

TAP TO REVEAL ANSWER

Depression is associated with _____ total REM sleep

increased

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial